ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

BNGO vs HBIO // EV/EBITDA & P/E VALUATION

Bionano Genomics Inc. (NASDAQ) VS. Harvard Bioscience Inc. (NASDAQ) • 15-METRIC TALLY: BNGO 1 — HBIO 5
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (BNGO VS. HBIO) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC BNGO HBIO SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 46.30% 57.70% -11.40 HBIO /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — 13.66% — TIE /fcf-yield <GO>
Operating Margin -60.00% -56.10% -3.90 HBIO /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -7.40% -8.10% +0.70 BNGO /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 5/9 -1.00 HBIO /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 34.4 68.8 -34.35 HBIO /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $16.8M $40.1M -$23.3M HBIO /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR BNGO REV HBIO REV BNGO GROSS % HBIO GROSS % BNGO FCF HBIO FCF
FY 2025 $28.5M $86.5M 46.3% 57.7% -$16.3M $5.5M
FY 2024 $30.8M $94.1M 1.2% 58.2% -$68.9M -$1.2M
FY 2023 $36.1M $112.3M — — -$125.2M $14.0M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
BNGO // BETA —
HBIO // BETA —